1116 related articles for article (PubMed ID: 32761155)
1. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
Greene DN
J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
[TBL] [Abstract][Full Text] [Related]
2. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
McAdam AJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
[No Abstract] [Full Text] [Related]
3. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
Williams E; Bond K; Zhang B; Putland M; Williamson DA
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
[No Abstract] [Full Text] [Related]
4. My Experience with SARS-CoV-2, with a Focus on Testing.
Cotter PA
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703893
[TBL] [Abstract][Full Text] [Related]
5. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
[No Abstract] [Full Text] [Related]
6. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
[No Abstract] [Full Text] [Related]
7. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
Lambert-Niclot S; Cuffel A; Le Pape S; Vauloup-Fellous C; Morand-Joubert L; Roque-Afonso AM; Le Goff J; Delaugerre C
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404480
[No Abstract] [Full Text] [Related]
8. The U.S. COVID-19 Testing Failure.
Todd B
Am J Nurs; 2020 Oct; 120(10):19-20. PubMed ID: 32976142
[TBL] [Abstract][Full Text] [Related]
9. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
[No Abstract] [Full Text] [Related]
10. Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
J Clin Virol; 2020 Jul; 128():104410. PubMed ID: 32403009
[No Abstract] [Full Text] [Related]
11. [Not Available].
Balavoine JF
Rev Med Suisse; 2020 Sep; 16(706):1726. PubMed ID: 32936565
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
[No Abstract] [Full Text] [Related]
13. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis.
Daruich A; Martin D; Bremond-Gignac D
J Fr Ophtalmol; 2020 May; 43(5):e167-e168. PubMed ID: 32327279
[No Abstract] [Full Text] [Related]
14. COVID-19 serologic testing: FAQs and caveats.
Kadkhoda K
Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
[No Abstract] [Full Text] [Related]
15. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.
Davies E; Whitfield T; Machin N; Ahmad S
J Clin Virol; 2020 Aug; 129():104449. PubMed ID: 32504943
[No Abstract] [Full Text] [Related]
16. Is reinfection possible after recovery from COVID-19?
Law SK; Leung AWN; Xu C
Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614
[No Abstract] [Full Text] [Related]
17. Empowering academic labs and scientists to test for COVID-19.
Steel JJ; Sitko JC; Adkins MG; Hasstedt SC; Rohrer JW; Almand EA
Biotechniques; 2020 Oct; 69(4):245-248. PubMed ID: 32584188
[No Abstract] [Full Text] [Related]
18. The explosion of new coronavirus tests that could help to end the pandemic.
Guglielmi G
Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
[No Abstract] [Full Text] [Related]
19. What to Expect from Antibody Assays of SARS-CoV-2?
Yi X; Cao J
J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
[No Abstract] [Full Text] [Related]
20. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
Gruer L; Bhopal R
BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
[No Abstract] [Full Text] [Related]
[Next] [New Search]